Skip to main content
HLB innoVation Co.,Ltd. logo

HLB innoVation Co.,Ltd. — Investor Relations & Filings

Ticker · 024850 ISIN · KR7024850000 KO Manufacturing
Open in API
Filings indexed 477 across all filing types
Latest filing 2020-11-17 Director's Dealing
Country KR South Korea
Listing KO 024850

About HLB innoVation Co.,Ltd.

https://www.hlbinnovation.com/

HLB innoVation Co., Ltd. is a technology company with a dual focus on the semiconductor and biotechnology sectors. The company's primary business involves the design, manufacture, and sale of essential electronic components, specializing in a wide range of lead frames for the semiconductor industry. Building on its technological foundation, HLB innoVation has expanded into the biopharmaceutical field. This division is dedicated to the research and development of innovative treatments for patients with diseases that are currently considered untreatable, aiming to provide new therapeutic options.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure by insiders (executives or major shareholders) regarding changes in their shareholdings, which falls under the category of 'Director's Dealing' (DIRS) as it tracks insider transactions and ownership changes.
2020-11-17 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when an entity's shareholding in a listed company crosses certain thresholds (typically 5%). This document details the change in shareholding by 'Kyung Nam Pharm Healthcare Co., Ltd.' in 'PSMC Co., Ltd.' due to market sales. It is a standard regulatory disclosure form, not an annual report, earnings release, or announcement of a report. Therefore, it falls under the 'Major Shareholding Notification' category.
2020-11-17 Korean
[기재정정]최대주주변경을수반하는주식양수도계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Change in Largest Shareholder' due to a stock transfer agreement. It is a formal disclosure of corporate ownership structure changes, which falls under the category of general regulatory announcements and filings that do not fit into specific financial reporting categories like 10-K or IR. Therefore, it is classified as a Regulatory Filing (RNS).
2020-11-13 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system, specifically titled 'Change of Largest Shareholder'. It details the change in the controlling interest of the company (PSMC), including the identity of the new largest shareholder, the number of shares involved, the reason for the change, and the financial background of the new entity. This type of disclosure is a standard regulatory requirement for public companies to report significant changes in ownership structure, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for individual insider trades) or 'Major Shareholding Notification' (which is typically for institutional investors crossing thresholds).
2020-11-13 Korean
반기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company PSMC, covering the period from April 1, 2020, to September 30, 2020. It contains detailed financial information, business operations, production data, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2020
2020-11-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details changes in share ownership by a major shareholder (Kyung Nam Pharm Healthcare Co., Ltd.) in the company PSMC. This type of filing is specifically designed to notify the market of significant changes in shareholding levels, which falls under the 'Major Shareholding Notification' category.
2020-11-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.